newdrugapprovals.org
BAYER 2013 AND BEYOND
Bayer With 11 treatments in Phase I trials, 8 in Phase II, and 13 in Phase III, Bayer has a strong pipeline. By far the most interest currently, given that the latest reports came out October 21st,…